Get Level 2

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. BVX.L Share Price
  4. BVX.L Share Regulatory News
  5. BiVictriX Therapeutics makes 'fundamental step forward'

Pin to quick picksBVX.L Regulatory News (BVX)

BVX.L Information
  • There is currently no data for BVX

BiVictriX Therapeutics makes 'fundamental step forward'

12 Dec 2022 11:38

BiVictriX Therapeutics PLC BiVictriX Therapeutics makes 'fundamental step forward' 12.12.2022 / 12:37 CET/CEST The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

12.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language:English
Company:BiVictriX Therapeutics PLC
United States
ISIN:GB00BNXH3K91
EQS News ID:1510657
 
End of NewsEQS News Service

1510657 12.12.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

12
Date   Source Headline
11th Sep 20247:00 amRNSCancellation - BiVictriX Therapeutics plc
10th Sep 202411:04 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSLast Day of Dealings
9th Sep 20247:00 amRNSPositive In Vivo Data from BVX002 Programme
2nd Sep 20245:04 pmRNSHolding(s) in Company
2nd Sep 20248:50 amRNSDirector Dealing
29th Aug 20245:05 pmRNSResult of General Meeting
28th Aug 202410:14 amRNSHolding(s) in Company
28th Aug 202410:12 amRNSHolding(s) in Company
19th Aug 20247:00 amRNSTR-1: Notification of major holdings
13th Aug 20247:00 amRNSGrant of Options
12th Aug 20247:00 amRNSProposed Voluntary Delisting
1st Aug 20247:00 amRNSInterim Results
24th Jul 20245:00 pmRNSResult of Annual General Meeting
26th Jun 20247:00 amRNSPublication of 2023 Annual Report & Notice of AGM
13th Jun 20247:00 amRNSCompelling Safety Profile of BVX001
6th Jun 20247:00 amRNSInnovate UK Grant Award to Accelerate ADC Pipeline
31st May 20248:44 amRNSBiVictriX – Full Year Results 2023
17th Apr 20247:00 amRNSOrphan Drug Designation & FDA INTERACT Meeting
28th Mar 20247:00 amRNSGrant of Options – PDMR/Director Dealings
4th Jan 202412:30 pmRNSHolding(s) in Company
4th Jan 202412:30 pmRNSHolding(s) in Company
4th Jan 20247:00 amRNSBiVictriX Hosts Inaugural Roundtable Discussion
5th Dec 202311:08 amRNSBoard Change
30th Nov 20237:00 amRNSPipeline update on BVX002
22nd Nov 20235:14 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSPatent Granted in Japan
12th Oct 20237:00 amRNSExtended Survival Rates Reported with BVX001
3rd Oct 20237:00 amRNSAppointment of Adrian Howd as CFO and CBO
19th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSTotal Voting Rights
23rd Aug 20237:00 amRNSUS Patent Granted
17th Aug 20237:00 amRNSHolding(s) in Company
16th Aug 20236:00 pmRNSHolding(s) in Company
11th Aug 20234:17 pmRNSHolding(s) in Company
8th Aug 20235:18 pmRNSResult of General Meeting
19th Jul 20236:16 pmRNSResult of Conditional Fundraise
19th Jul 202312:31 pmRNSProposed Fundraise in excess of £2 million
17th Jul 20237:00 amRNSPositive final data in preclinical efficacy study
19th Jun 20237:00 amRNSPositive interim data
6th Jun 20237:00 amRNSBiVictriX nominates clinical candidate for BVX001
4th May 20234:36 pmRNSResult of Annual General Meeting
31st Mar 20237:00 amRNSPublication of Annual Report and Notice of AGM
30th Mar 20237:00 amRNSBiVictriX Full Year Results
1st Mar 20237:01 amRNSAppointment of Alex Hughes as CFO
31st Jan 20237:08 amRNSBiVictriX reports positive BVX001 preclinical data
24th Jan 20234:21 pmRNSHolding(s) in Company
19th Jan 202311:00 amRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
16th Jan 20234:32 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SPO
SPO.L
LSE
0.00%
GRN
GRN.L
LSE
0.00%
RDW
RDW.L
LSE
0.00%
AWE
Alphawave Ip
LSE
0.00%
EBOX
Tritax Eurobox
LSE
0.00%
Trending
FORG
Forgent
LSE
6.06%
GST
GSTechnologies
LSE
5.88%
ORCP
Oracle Power
LSE
18.18%
GEX
Georgina Energy
LSE
-5.26%
KEFI
Kefi Gold & Copper
LSE
0.00%